Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCOUT-CKD
NCT07325201Phase 2Not yet recruiting
- Sponsor
- HealthPartners Institute
- Start
- Jan 2027
- Primary completion
- Feb 2029
- Countries
- 1
01
Overview
A Phase 2 trial of sotagliflozin in type 1 diabetes mellitus (T1D), chronic kidney disease (CKD), sponsored by HealthPartners Institute. Planned start Jan 2027; status: not yet recruiting.
02
Drugs
sotagliflozin
03
Conditions
type 1 diabetes mellitus (T1D)chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT07325201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07325201.